Literature DB >> 12063117

Effect of heparin chain length on the interaction with tissue factor pathway inhibitor (TFPI).

Xinyan Xu1, Ryo Takano, Yoshihisa Nagai, Tadatoshi Yanagida, Kaeko Kamei, Hisao Kato, Yuichi Kamikubo, Yo Nakahara, Kosuke Kumeda, Saburo Hara.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a heparin-binding protein involved in the extrinsic blood coagulation system. In order to elucidate the minimal size of heparin chain required for the interaction with TFPI, we prepared a series of heparin-derived oligosaccharides with tailored chain length ranged from disaccharide to eicosasaccharide after the successive treatments of heparin, including partial N-desulphation, deaminative cleavage with nitrous acid and gel-filtration. Affinity chromatography study of each oligosaccharide fraction using TFPI as the ligand indicated that increasing the degree of polymerisation causes increased affinity, and that a remarkable change in the affinity occurs between the decamers and dodecamers. Measurement of factor Xa inhibitory activity of TFPI in the presence of each oligosaccharide fraction indicated that the fractions shorter than dodecamers only slightly enhanced the TFPI activity for factor Xa inhibition, while the fractions larger than octadecamers had an effect comparable to full-length heparin. These were compatible to the results from the kinetic analyses of the interaction between TFPI and heparin-derived oligosaccharide with an evanescent wave-based biosensor system, IAsys, using a TFPI C-terminal peptide as the ligand.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063117     DOI: 10.1016/s0141-8130(02)00015-6

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Effect of heparin oligomer chain length on the activation of valvular interstitial cells.

Authors:  Sara Pedron; Andrea M Kasko; Carmen Peinado; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

2.  Molecular mechanisms of heparin-induced modulation of human interleukin 12 bioactivity.

Authors:  Khue G Nguyen; Francis B Gillam; Jared J Hopkins; Srinivas Jayanthi; Ravi Kumar Gundampati; Guowei Su; Jenifer Bear; Guy R Pilkington; Rashmi Jalah; Barbara K Felber; Jian Liu; Suresh Kumar Thallapuranam; David A Zaharoff
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

3.  Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides.

Authors:  Qing Ma; Mahmut Tobu; Christopher Schultz; Walter Jeske; Debra Hoppensteadt; Jeanine Walenga; Umberto Cornelli; John Lee; Robert Linhardt; Israel Hanin; Jawed Fareed
Journal:  Thromb Res       Date:  2006-07-07       Impact factor: 3.944

4.  Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Umesh R Desai; Alan E Mast
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

5.  The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system.

Authors:  J Hogwood; A Naggi; G Torri; C Page; P Rigsby; B Mulloy; E Gray
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

6.  Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates.

Authors:  Ahmed Kouta; Debra Hoppensteadt; Emily Bontekoe; Walter Jeske; Richard Duff; Lee Cera; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.